ACM
KURA icon

ACT Capital Management’s Kura Oncology KURA Stock Holding History

ACT Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$975K Buy
88,900
+15,000
+20% +$142K 0.64% 26
2026
Q1 		$601K Hold
73,900
– – 0.47% 25
2025
Q4 		$768K Buy
+73,900
New +$775K 0.62% 30

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

ACT Capital Management's KURA Position: Q2 2026 in Review

ACT Capital Management increased its Kura Oncology (KURA) stake by 20% in Q2 2026, buying an estimated $142K and bringing the position to 88,900 shares worth $975K. The position accounts for 0.64% of the portfolio, ranked #26.

ACT Capital Management first reported a position in KURA in Q4 2025 and has held it in 3 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • ACT Capital Management held 88,900 shares of Kura Oncology worth $975K as of Q2 2026.
  • ACT Capital Management bought 15,000 Kura Oncology shares in Q2 2026, an estimated $142K.
  • Kura Oncology made up 0.64% of ACT Capital Management's portfolio in Q2 2026, its #26 holding.
  • ACT Capital Management first reported a position in Kura Oncology in Q4 2025 and has held it in 3 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on ACT Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.